Physician profile
Sumit Das
NPI 1932180429
$27,763.30
in general payments reported to CMS, 2019-2025
13 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $63.20 · 2021: $1,253 · 2022: $209 · 2023: $21.32 · 2024: $785 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,576 · Travel and Lodging: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,576.03 |
| Travel and Lodging | $546.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $21,000.00 | 2019 | |
| Globus Medical, INC. | $6,241.82 | 2019-2025 | Excelsius Gps, Creo, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $148.40 | 2022 | |
| Ebi, LLC | $64.78 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Spf Xl Iib Implantable Spinal Fusion Stimulator |
| Boston Scientific Corporation | $58.80 | 2025 | Intracept |
| Orthofix Medical, INC. | $48.56 | 2023-2025 | Cervical-Stim, Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $39.41 | 2020 | |
| Smith+Nephew, INC. | $36.09 | 2019 | |
| Cerapedics INC. | $29.47 | 2021 | |
| Abbott Laboratories | $29.29 | 2022 | |
| Ethicon US, LLC | $23.79 | 2020 | |
| Hikma Pharmaceuticals USA | $22.05 | 2021 | |
| Misonix INC | $20.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.